VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1482454
Sex: F
Age:
State: NY

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: face was red andflushed; had a warm and fuzzy numbfeeling; kind of felt weird; metallic taste; headache; face was red andflushed; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN620S) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included fibroids, asthma and pre-diabetic. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), salbutamol (ALBUTEROL), montelukast (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (TRI-LO-SPRINTEC) and vitamin b12 (MANUFACTURER UNKNOWN). The patient had a history of allergy to penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Mar2021 at 11:45, the patient felt her face was red and flushed and had a warm and fuzzy numb feeling, kind of felt weird, and had a metallic taste. The patient also experienced headache all day and the next day. Since the vaccination, the patient had been tested for COVID-19 which included a COVID-19 virus test on 26Mar2021 and the result was pending. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face was red and flushed, numbness, weird feeling, metallic taste was resolved on 23Mar2021 at 12:45 while the clinical outcome of the event headache was resolved on 24Mar2021. No follow-up attempts are needed. No further information expected.

Other Meds: SPIRONOLACTONE; METFORMIN; Albuterol; MONTELUKAST; VITAMIN D NOS; vitamin b12; TRI-LO-SPRINTEC

Current Illness:

ID: 1482455
Sex: M
Age:
State:

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, after 12 hours of vaccination at 23:00, the patient experienced shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were provided for the reported events. The clinical outcome of the events shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion were resolved with lasting effects at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; Flonase

Current Illness:

ID: 1482456
Sex: F
Age:
State: MI

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: soreness at injection site and in armpit.; soreness in armpit of the same arm as injection site; This is a spontaneous report from a contactable consumer. A 63-years-old adult non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732), via unspecified route of administration on 20Mar2021 at 14:15, (at the age of 63 years) as a single dose for COVID-19 immunisation on left arm. Medical history was not reported. Concomitant medications were not reported. The patient also received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205), via unspecified route of administration on left arm on 04Mar2021, (at the age of 63 years) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 26Mar2021 the patient experienced soreness at injection site and in armpit of the same arm as injection site. The patient did not receive any treatment for adverse event soreness at injection site and arm pit of the same arm as injection site. The clinical outcome of the event soreness at injection site and arm pit was recovering. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1482457
Sex: F
Age:
State: CA

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Chills; slightly sore at injection site; nausea; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take receive any other medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 20:00, the patient experienced chills, slightly sore at injection site and nausea. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, vaccination site pain and nausea were unknown at the time of this report. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482458
Sex: F
Age:
State: TX

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain at injection site; High fever; Body shaking; Headache; Chills; Sweats; Felt very nauseated like a had a hang-over for a week.; Blistery rash on my back; This is a spontaneous report received from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: FL9266), via an unspecified route of administration in the left arm on 13Feb2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included blood pressure medication, thyroid medication and estrogen (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL9262), via an unspecified route of administration in the left arm on 23Jan2021 at 09:30 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 13Feb2021 at 20:00 (after 13 hours of second vaccination), the patient experienced pain at injection site, high fever, body was shaking, headache, chills and sweats which existed for 14 hours. On an unspecified date in 2021, the patient felt nauseated like a hangover for a week. The patient also had a blistery rash on her back that was scabbing over at the time of this report. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pain at injection site, high fever, body shaking, headache, chills, sweats were recovered on 14Mar2021; nauseated was recovered on an unspecified date and blistery rash was not recovered at the time of this report. No follow-up attempts possible. No further information expected.

Other Meds: ESTROGEN

Current Illness:

ID: 1482459
Sex: F
Age:
State: GA

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via unspecified route of administration in the arm left on 26Mar2021 at 11:15 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via unspecified route of administration in the left arm on 04Mar2021 at 10:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 27Mar2021 at 03:00, the patient experienced diarrhea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of the events diarrhea and fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1482460
Sex: F
Age:
State: UT

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Exhausted/tired; Headaches; Have not been able to get warm; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Mar2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included fertilization issues. The patient did not have any known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for fertility reasons but not diabetic, topiramate (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), lisdexamfetamine mesilate (VYVANSE) and omeprazole (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021, the patient was not able to get warm. On 27Mar2021, the patient had headaches and from 28Mar2021, the patient felt exhausted and did not remember being so tired for so many days in a row after the vaccination. Therapeutic measures taken included treatment with alternated TYLENOL and ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events exhausted, not able to get warm and headaches were recovered with sequelae on an unknown date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN; TOPIRAMATE; Sertralin; VYVANSE; OMEPRAZOLE

Current Illness:

ID: 1482461
Sex: F
Age:
State: NY

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Knee is so swollen that he cannot stand up/walk; knee is so swollen that he cannot stand up/walk; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown); via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 19:30, the patient experienced swollen knee that she cannot stand up/walk. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the knee swelling and walking difficulty was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1482462
Sex: F
Age:
State: NJ

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Fatigue; joint pain; aches; headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via an unspecified route of administration on the left arm on 24Mar2021 at 13:15 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Concomitant medications included duloxetine hydrochloride(CYMBALTA) and sertraline hydrochloride(ZOLOFT) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 11:30, patient experienced fatigue, joint pain, aches and headache. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, joint pain, aches and headache was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; CYMBALTA

Current Illness:

ID: 1482463
Sex: M
Age:
State: OH

Vax Date: 02/05/2021
Onset Date: 02/10/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: SIMVASTATIN

Current Illness:

ID: 1482464
Sex: M
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: very bad neck cramps; gave headache; blurry vision now; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: box-18) via an unspecified route of administration in the arm left on 29Mar2021 at 09:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergies to medications, food, or other products. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and fluticasone propionate(FLONASE) on unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was reported as unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00 PM the patient experienced very bad neck cramps, had headache and blurry vision. It was unknown if the patient took any treatment for the reported adverse events. The event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the events was unknown at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: XYZAL; Flonase

Current Illness:

ID: 1482465
Sex: M
Age:
State: GA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Chills; Fever; Repeated vomiting; Muscle aches; Felt bad since taking shot; This is a spontaneous report from a contactable consumer. A 71-year-old male patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 08:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included brain tumor operation and colectomy. The patient did not take any concomitant medications. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021, the patient experienced chills, fever, muscle ache, fever, repeated vomiting and felt bad after vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received unknown treatment for the reported events. The clinical outcome of chills, fever, muscle ache, fever, repeated vomiting and feeling bad were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482466
Sex: F
Age:
State: IL

Vax Date: 03/26/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 26Mar2021 at 11:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient had no allergies to medications, food, or other product. Concomitant medication included unspecified medications within two weeks of vaccination for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 05:00, five days after the vaccination, the patient experienced swollen lymph node under left arm, the arm that got the shot in. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node under left arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482467
Sex: F
Age:
State: NJ

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Brain fog; Elevated heart rate; body pain; Lethargy; Headache; Body pain esp in joints; High temperature of 101.4 (typical was 97.7); This is a spontaneous report from a contactable consumer, the patient. A 49-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in left arm on 24Mar2021 at 16:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no known allergies. Concomitant medications included Multivitamin (MANUFACTURER UNKNOWN) and Melatonin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in left arm on 03Mar2021 at 18:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 05:45, the patient experienced experienced elevated heart rate and noticed it would not decrease with rest/laying down and was able to track with a Garmin device. It ranged from a low of 90 to a high of 136, typical resting HR is 65-75. Brain fog was what would consider very high, typically, the patient process info quickly, felt like could feel brain trying to work. The patient also experienced high temperature of 101.4 (typical was 97.7), headache, body pain especially in joints, lethargy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lethargy, high temperature, headache, body pain, joint pain and elevated heart rate and brain fog was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MELATONIN

Current Illness:

ID: 1482468
Sex: F
Age:
State: OH

Vax Date: 03/28/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Headaches for 2 days; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 10:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included escitalopram oxalate (LEXAPRO) and galcanezumab (EMGALITY); both for unknown indication since an unknown date. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 06:00, the patient experienced headaches for two days and fatigue. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache was resolved on 01Apr2021, while that of the event fatigue was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; Emgality

Current Illness:

ID: 1482469
Sex: F
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Soreness of arm; Stiff muscles in movement of arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EAU), via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, compromised immune system due to chemotherapy, high blood pressure (HBP), irregular heart rate, chondromalacia of both legs, chronic depression and bipolar. The patient previously received morphine and experienced a drug allergy. Prior to the vaccination, the patient had undergone a COVID-19 test twice, on an unspecified date in the year 2020 and another test was on 01Sep2020; she tested negative both the times. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 17:30, the patient experienced soreness in arm, very stiff muscles in movement of arm. On the same day, the patient had brief headache that did not last. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date in Mar2021, after the vaccination, the patient underwent a COVID-19 test (nasal swab), and tested negative. No therapeutic measures were taken for any of the reported events. The clinical outcome of the events soreness in arm, stiff muscle in movement of arm were resolving at the time of this report. The clinical outcome of the event headache was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482470
Sex: F
Age:
State: MD

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: rapid HBR of 125 BPM; blood pressure of 145/82; Very uncomfortable; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on 26Mar2021 at 12:00(at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included estradiol (ESTROGEN) and progesterone (MANUFACTURER UNKNOWN) for unknown indication and start date. Patient did not have any allergies to food, medications and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 13:00 the patient experienced rapid HBR of 125 BPM and blood pressure of 145/82. It was very uncomfortable and started afternoon the day after and continued until early Sunday a.m. On an unknown date, the patient underwent HBR and the result was 125 BPM. On an unknown date, the patient underwent blood pressure and the result was 145/82 (unknown unit). The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rapid HBR of 125 BPM, blood pressure of 145/82 and feeling abnormal were unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTROGEN; PROGESTERONE

Current Illness:

ID: 1482471
Sex: M
Age:
State: FL

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Joint pain; Tennis elbow; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL6199), via an unspecified route of administration in the right arm on 04Mar2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 10Feb2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021, the patient experienced joint pain in many joints that dissipated. The pain was dissipated in all joints within a week except in left elbow. The left elbow had exacerbated into tennis elbow. It was still hurting as of the end of March. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of join pain and tennis elbow were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482472
Sex: F
Age:
State: NJ

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Chills through the night; fever; headache; pain in the left arm; body ache (back); This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247) via an unspecified route of administration in right arm on 30Mar2021 at 11:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included allergies. Concomitant medication received within two weeks of vaccination included Xyzal for allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 09Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. On 31Mar2021 at 00:00, the patient experienced chills through the night, fever, headache, pain in the left arm and body ache (back). No therapeutic measure was taken for the events experienced. The event neither resulted in doctor or other healthcare professional office/clinic visit nor in emergency room/department or urgent care. The clinical outcome of the events chills through the night, fever, headache, pain in the left arm and body ache (back) was resolved with lasting effects. No follow-up attempts are needed. No further information is expected.

Other Meds: XYZAL

Current Illness:

ID: 1482473
Sex: F
Age:
State: FL

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Immediate tingling (pins & needles)/ Over course of1 hour same symptom moved to add left hand, then right and left foot.; Physical coldness (very cold) inright hand (all fingers).; Physical coldness (very cold) inright hand (all fingers). Over course of1 hour same symptom moved to addleft hand, then right and left foot.; This is a spontaneous report from a contactable consumer, the patient. A 47-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an unspecified route of administration in the left arm on 20Mar2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food, or other products. Concomitant medications included unspecified antihistamine (MANUFACTURER UNKNOWN), and WAL-PHED D (MANUFACTURER UNKNOWN); both for an unknown indication and from on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 15:00, the patient experienced immediate tingling (pins & needles) and physical coldness (very cold) in right hand (all fingers). Over course of 1-hour, the same symptom moved to "add" left hand, then right and left foot. (Right hand symptoms longest and most intense and felt very similar to cortisone shot given for carpal tunnel syndrome). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events included oxygen & pulse check (Pulse Oximetry test). The clinical outcomes of the event tingling (pins & needles), physical coldness (finger cold) in right hand (all fingers), cold feet and hands (very cold) were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482474
Sex: F
Age:
State: VA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Right ear clog can't hear feels like fluid; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number- UNKNOWN), via an unspecified route of administration in the right arm on 30Mar2021 at 10:00 (at the age of 57-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had history of allergy to penicillin. The patient did not receive any concomitant medication. Prior to vaccination the patient was diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 10:00, patient experienced right ear clog and reported that he could not hear and it felt like fluid. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ear clog can't hear felt like fluid were not resolved. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482475
Sex: F
Age:
State: NY

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Massive headaches; very bad arm pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the arm right on 22Mar2021 at 13:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and diagnosed COVID-19. The patient had no allergies to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) and venlafaxine (MANUFACTURER UNKNOWN) taken for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 the patient experienced massive headaches and very bad arm pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of events massive headaches and very bad arm pain were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE; VENLAFAXINE

Current Illness:

ID: 1482476
Sex: F
Age:
State: GA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203) via unspecified route of administration in the left arm on 30Mar2021 at 09:30 as a single dose for COVID-19 immunisation (at the age of 38-years-old). Medical history included meniere's disease. The patient reported no allergies to medications, food and other products. Concomitant medication was claritin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 30Mar2021 at 10:00 (30 minutes after), the patient experienced the shot she developed a loud ringing in her ears and sounds became amplified. 24 post vaccination there had not been any improvement. The tinnitus was very loud and the amplified noises are uncomfortable. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had not received treatment for event. The clinical outcome of event tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Claritin

Current Illness:

ID: 1482477
Sex: F
Age:
State: FL

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Nausea; Headache; Fever; This is a spontaneous report from contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) in the left arm on 29Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included high blood pressure and idiopathic intracranial hypertension (IIH). The patient had a known allergy to sulfur medication. The patient's concomitant medications included amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and fexofenadine hydrochloride (Allegra) all from unknown dates for an unknown indications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA, lot Number: EN 6204) in the left arm on 08Mar2021 at 08:15 (at the age of 43-years-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021, the patient experienced nausea, headache and fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of headache, fever and nausea. The clinical outcome of the events of nausea, headache and fever was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE; ATORVASTATIN; Zyrtec; ALLEGRA

Current Illness:

ID: 1482478
Sex: F
Age:
State: AR

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Body and Muscle cramps; Confused; Foul taste in mouth; Foul smell; Severe headache; Couldnt walk, Trouble walking; Black rings developed under eyes; Body burns; Fell asleep while talking; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as yes, however medical history was unspecified. Concomitant medications were taken within two weeks of vaccination was reported; however, it was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, at 06:00, the patient experienced body and muscle cramps, confusion, falling asleep while talking, foul taste in mouth, foul smell, unable to walk, severe headache, body burns, black rings developed under eyes, trouble walking. The patient had not received any treatment for the reported events. The clinical outcome of the events muscle cramps, confusion, taste peculiar, smell change, headache, difficulty in walking, dark circles under eyes, body temperature increased and sleepiness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482479
Sex: F
Age:
State: NJ

Vax Date: 03/22/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534), via an unspecified route of administration on 22Mar2021 at 11:30 (at the age of 45-year-old), as a single dose for COVID-19 immunization. The patient had no medical history. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) and B vitamin (MANUFACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on the left arm on an unknown date, as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. On 29Mar2021 at 08:00, the patient experienced feeling extremely fatigued and some muscle pain throughout the body. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue extreme and muscle pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Multivitamin; VITAMIN B

Current Illness:

ID: 1482480
Sex: F
Age:
State: TX

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Red dots on both arms and legs.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737), via an unspecified route of administration in the right arm on 30Mar2021 at 17:00 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the right arm on 09Mar2021 at 14:00 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 07:00 (After 12 hours), the patient developed red dots on both arms and legs. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the red dots on both arms and legs. The clinical outcome of the event red dots on both arms and legs was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482481
Sex: M
Age:
State: SC

Vax Date: 03/09/2021
Onset Date: 03/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: SEVERE VERTIGO; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the arm left on 09Mar2021 at 12:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history was reported no. The patient did not receive concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6200) via an unspecified route of administration in the arm left on 16Feb2021 at 13:00 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior the vaccination. The patient did not have Allergies to medications, food, or other product. On 15Mar2021 at 08:45 the patient was experienced severe vertigo. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of severe vertigo was ongoing. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482482
Sex: M
Age:
State: MI

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever (102.5F); Headache; Muscle pain; Fast heartbeat; This is a spontaneous report from a contactable consumer, the patient. A 49-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 at 12:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Mar2021 at 18:00, the patient experienced fever (102.5F), headache, muscle pain, fast heartbeat. On an unknown date, the patient underwent body temperature measurement and the result was 102.5F. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures taken for the events. The clinical outcome of the event fever (102.5F), headache, muscle pain and fast heartbeat was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482483
Sex: F
Age:
State: AZ

Vax Date: 03/19/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Upper respiratoryinfection, laryngitis.; Fatigue; Sore throat; Severe migraine; Slight cough; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 07:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included heart murmur, pituitary adenoma, hearing impaired and exercise induced asthma. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 13:00, the patient experienced severe migraine and slight cough. On 28Mar2021, the patient experienced cough, sore throat, fatigue and on 31Mar2021, the patient experienced upper respiratory infection, laryngitis. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. The patient received unspecified antibiotics, steroids and inhaler as a treatment for the events. The clinical outcome of the event migraine, cough, sore throat, fatigue and upper respiratory infection, laryngitis were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482484
Sex: F
Age:
State: SC

Vax Date: 03/12/2021
Onset Date: 03/13/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Tinnitus, ringing in the ears.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 12:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The concomitant medications of the patient included levothyroxine 88mg (MANUFACTURER UNKNOWN) from an unknown date and for unknown indications. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 03:00, the patient experienced the event tinnitus (ringing in the ears). On 22Mar2021, the patient underwent COVID-19 virus test and the result was negative. The event resulted in doctor or other healthcare professional office/clinic visit and visit to emergency room/department or urgent care. Therapeutic measures were taken as a result of the event tinnitus and included treatment with antibiotics from an unknown date. The clinical outcome of the event tinnitus was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1482485
Sex: M
Age:
State: OH

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: My ears keep popping as if I am changing altitude. This happens every time I swallow; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150), via an unspecified route of administration in right arm on 31Mar2021 at 08:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. Concomitant medication included naproxen sodium (ALEVE) from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not tested for COVID-19 since the vaccination. On 31Mar2021, at 10:15, the patient experienced ear popping sensation, as if he was changing altitude which happened every time he swallowed. No treatment was received for the adverse event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of ear popping sensation was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: ALEVE

Current Illness:

ID: 1482486
Sex: F
Age:
State: CA

Vax Date: 03/25/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Full body rash, legs, arms, stomach and back.; shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8732) via an unspecified route of administration in the left arm on 25Mar2021 at 14:30 (at the age of vaccination 40-years-old) as a single dose for COVID-19 immunisation. The patient medical history included asthma, GERD, gastritis. The patient previously had drug allergy while taking amoxicillin (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and advil (MANUFACTURER UNKNOWN). Concomitant medications included famotidine (PEPCID), paracetamol (TYLENOL), vitamin D (MANUFACTURER UNKNOWN), prenatal vitamins (MANUFACTURER UNKNOWN) since an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 17:30, the patient experienced full body rash on legs, arms, stomach and back and shortness of breath. The patient had received BENADRYL (MANUFACTURER UNKNOWN), CLARITIN (MANUFACTURER UNKNOWN) as treatment for the events. The adverse events resulted in emergency room/department or urgent care. The clinical outcome for the events rash and shortness of breath were recovered with lasting effects at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: Pepcid; TYLENOL; Vitamin d; Prenatal vitamins

Current Illness:

ID: 1482487
Sex: F
Age:
State: NC

Vax Date: 03/15/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Fever; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration on 15Mar2021 at 08:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration on 18Feb2021 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021, the patient experienced fever. The patient did not receive any treatment for the adverse events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event fever was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482488
Sex: F
Age:
State: FL

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Vaccine location : Left leg; Itching through out my body for fewdays.; This is a spontaneous report from a contactable consumer, the patient. A 64-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the leg left on 29Mar2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient did not take any concomitant medications. The patient was allergic to pet's and certain foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 00:00, the patient experienced itching throughout body for few days. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the itching. The clinical outcome of the event itching throughout body was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482489
Sex: F
Age:
State: IL

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Extreme soreness in vaccinated arm; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8130) via an unspecified route of administration in the arm left on 29Mar2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient did not have any known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 16:00 (beginning the evening of vaccinated day), the patient experienced extreme soreness in the vaccinated arm. The patient did not receive any treatment for the adverse event. The clinical outcome of the event extreme soreness in vaccinated arm was resolved on 30Mar2021 (thru Tuesday). No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482490
Sex: M
Age:
State: CA

Vax Date: 03/08/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe gout flare in left foot.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ep6955) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 36-year-old) at 18:30 as a single dose for COVID-19 immunisation. Medical history included gout and psoriasis. Concomitant medications included colchicine (MANUFACTURER UNKNOWN) from an unknown date and dietary supplements from an unknown date for an unknown indication. The patient was allergic to penicillin and aspirin. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6206) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 36-year-old) at 19:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 30Mar2021 at 07:30, 13 hours after the vaccination, the patient experienced a severe gout flare in the left foot. The event resulted in a doctor or other healthcare professional office/clinic visit. The patient was treated with colchicine for the reported event. The clinical outcome of the event gout flare was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: COLCHICINE

Current Illness:

ID: 1482491
Sex: M
Age:
State: MD

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: sore arm; slight headache; flu like feelings; right shoulder became extremely sore for several days (unable to use right arm).; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 78-years-old), as a single dose for COVID-19 immunisation. Medical history included dislocated shoulder. The patient was allergic to sulfa and sun screen. Concomitant medications included benazepril (MANUFACTURER UNKNOWN), finasteride (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 05Mar2021 at 17:30 (at the age of 78-years-old), as a single dose for COVID-19 immunisation. The patient previously received lidocaine (MANUFACTURER UNKNOWN) and epinephrine (MANUFACTURER UNKNOWN); and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-1. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, the patient experienced sore arm, slight headache and flu like feelings for several days. In addition, the right shoulder became extremely sore for several days (unable to use right arm). It was reported that the right shoulder dislocated 3 times beginning in 1965 through 1996 and the shoulder was almost completely normal after 5 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of sore arm, slight headache, flu like feelings and right shoulder became extremely sore for several days (unable to use right arm) was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BENAZEPRIL; FINASTERIDE; SIMVASTATIN; METOPROLOL

Current Illness:

ID: 1482492
Sex: F
Age:
State: FL

Vax Date: 03/21/2021
Onset Date: 03/21/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Difficulty swallowing; Headache; Stiffness in limb; Pain; Chills; Blister on lip; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: 6N6808), via an unspecified route of administration in the left arm on 21Mar2021 at 14:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and hypertension. The patient previously received sulphur (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN), salbutamol sulfate (VENTOLIN) and fluticasone propionate, salmeterol xinafoate (SERETIDE); all for an unknown indication from an unknown date. Prior to vaccination, patient was not diagnosed with COVID-19. since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 21:00, the patient experienced difficulty swallowing within seconds of the vaccine, headache and stiffness in limbs and pain, blister on lip after chills. It was unknown if the patient had received any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty swallowing, headache, stiffness in limbs, pain, chills and lip blisters was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VALSARTAN; ATENOLOL; Ventolin; SERETIDE

Current Illness:

ID: 1482493
Sex: F
Age:
State: FL

Vax Date: 03/09/2021
Onset Date: 03/13/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Tired; headache; vertigo; Feeling hot; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Mar2021 at 11:15 (at the age of 56-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:1470) via an unspecified route of administration in the arm left on 30Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer survivor, hashimoto's hypothyroidism (hashimoto's disease), and asthma. The patient had known allergies to sulfa and gadolinium MRI contrast dye (contrast media dye allergy). Concomitant medications included venlafaxine hydrochloride (EFFEXOR), tamoxifen (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), ibuprofen (ADVIL) and meclozine (MECLIZINE) ; from an unspecified date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021, the patient felt tired and spicy (feeling hot) for a couple of day following injection then one day with headache, followed by vertigo until date of second vaccine. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures taken included self-medication with meclizine hydrochloride. The clinical outcome of the events tired and spicy, headache and vertigo were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: EFFEXOR; TAMOXIFEN; LEVOTHYROXINE; Advil; Meclizine

Current Illness:

ID: 1482494
Sex: F
Age:
State: CT

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 at 15:00 (at the age of 48-year-old) as a single dose for COVID-19 immunization. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 14:30 (at the age of 48-year-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within four weeks, prior to the vaccination. On 31Mar2021 at 05:00, the patient experienced fever 100.1 (units unspecified), chills, achiness, and exhaustion starting around 12-18 hours after the second dose was administered. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fever 100.1 (units unspecified), chills, achiness and exhaustion. The clinical outcomes of the events fever 100.1, chills, achiness, and exhaustion were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482495
Sex: F
Age:
State: IL

Vax Date: 03/24/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: loss of sense of smell; This is a spontaneous report from a contactable consumer. A 50-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT) and seasonal allergies. The patient had no known allergies. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN); both were taken for an unknown indication and within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 09:00, one week after the vaccine, the patient experienced loss of sense of smell, which lasted approximately 1 week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event loss of sense of smell was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; METOPROLOL

Current Illness:

ID: 1482496
Sex: F
Age:
State: OH

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Extreme pain injection site; Extreme pain injection site up to the neck; This is a spontaneous report from a contactable consumer, the patient. A 63-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN), via an unspecified route of administration on right arm on 19Mar2021 at 18:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included Bipolar II, Lymphodema. Patient has known allergies to remeron, clonazepam, Sulfa and tape (adhesive tape allergy). Concomitant medications included calcium 600 plus vitamin D (MANUFACTURER UNKNOWN); taken for an unknown indication from an unknown start date. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19Mar2021 at 19:00, the patient experienced extreme pain at injection site up to the neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events extreme pain at injection site up to the neck were not resolved at the time this this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CALCIUM 600 PLUS VITAMIN D

Current Illness:

ID: 1482497
Sex: F
Age:
State: FL

Vax Date: 03/22/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: throat felt tight; swelling over the body, really bad over the body and face, she noticed that I am still filled with fluid; She thought she had an allergic reaction to the new environment; She looks like an Alien from outer space and thought was it was the vaccine. She has not felt quite right. She felt a little off; swelling over the body, really bad over the body and face, she noticed that I am still filled with fluid; facial and eye swelling; facial and eye swelling; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot number: EN6208, Expiration Date: Unknown), via an intramuscular, administered in left arm in the muscle on 22Mar2021 at 17:15 (at the age of 56-year-old) as a single dose for covid-19 immunisation at Clinic. The patient had no medical history and did not administered any concomitant medications. No additional vaccines administered on same date of the Pfizer Suspect and no prior vaccinations received within 4 weeks. The patient family medical history was none. Relevant lab tests were not performed. After the first dose of Pfizer covid 19 vaccine on 22Mar2021, she flew out of town the next day, 24 hours later, and about 3 days into her trip away on 26Mar2021, she noticed her face (facial) and eyes became swollen, was reported as worsened. She is home now, and it did not go away. She thought she had an allergic reaction to the new environment. Her eyes are so swollen, and her throat felt tight (throat tightening) on 29Mar2021. It was unknown and it was progressively happening. She has taken Benadryl. She just thought it was a change in environment because she was in a desert environment and she lived in a humid environment. She looks like an Alien from outer space and thought was it was the vaccine. She has not felt quite right and felt a little off. No emergency room or physician office required for the events. She stated that she went to urgent care because they are not going away, was chalking it up to her traveling and being on the plane as she was in dry desert air and lived in humidity. She had been home several days, it was not going away with Benadryl or anything. It was 3 to 4 days later, she got treated at urgent care, because her reaction was swelling over the body, really bad over the body and face. They put her on prednisone for 5 days to reduce the swelling. Patient came today (as per report) from her OB, GYN, and she noticed that she was still filled with fluid. She is reluctant to tell her whether to get the second dose or not and enquired whether it is safe to get the second dose, which is due on monday. She did not require an epi pen and not a hypochondriac. This doctor also told her, that she believes you can get it up to 42 days later. She would like to know if there are any other people who are experiencing this side effects. The reporter assessed the events as non-serious. The outcome of the events facial and eye swelling, throat felt tight, swelling over the body, really bad over the body and face was not recovered and the rest of the events was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1482498
Sex: M
Age:
State: CT

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: severe chills; feeling hot at night; Headache; General body ache.; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration on the left arm on 30Mar2021 (at the age of 25-year-old) at 13:30, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration on the left arm on 09Mar2021, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 31Mar2021 at 04:00, the patient experienced severe chills, feeling hot, headache and general body pains. Therapeutic measures were taken for all the events severe chills, feeling hot, headache and general body pains with advil 400mg only one time. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe chills, feeling hot, headache and general body pains were recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482499
Sex: F
Age:
State: UT

Vax Date: 03/29/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Left arm pit swollen and sore; Left arm pit swollen and sore; This is a spontaneous report from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included osteopenia. The patient received other medication within two weeks of vaccination which included Vitamin D (MANUFACTURER UNKNOWN) and a Multi-Vitamin for unknown indication. The patient received vaccine within four weeks prior to the vaccination which included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 17:00 the patient experienced left arm pit swollen and sore. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events left arm pit swollen and sore was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds: Vitamin d

Current Illness:

ID: 1482500
Sex: M
Age:
State: AZ

Vax Date: 03/06/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: headache/progresses to bad headache after a week; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Mar2021 at 12:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. The concomitant medication included High blood medicine and ibuprofen (MANUFACTURER UNKNOWN).Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On 08Mar2021 at 04:00, the patient experienced headache and then headache progresses to bad headache after a week. On an unknown date in Mar2021, (last week as reported) the patient had dizziness when he moves, the patient still had and reported that he was not able to report to work. The adverse events resulted in a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measure taken as a result of the event headache included ibuprofen (MANUFACTURER UNKNOWN) taken three times everyday. The clinical outcome of the event headache/progresses to bad headache after a week and dizziness was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482501
Sex: F
Age:
State: UT

Vax Date: 03/08/2021
Onset Date: 03/12/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Rash on neck; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 16:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patients medical history included osteopenia. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) and a multi-vitamin (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 08:00, the patient experienced rash on neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of rash on neck and included treatment with triamcinolone 0.1% Cream, prescribed by dermatologist. The clinical outcome of the event rash on neck was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VIT D

Current Illness:

ID: 1482502
Sex: F
Age:
State:

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Unknown) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and mixed connective tissue disease. Concomitant medication was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 23Mar2021, the patient experienced severe diarrhea. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the event severe diarrhea was resolving at the time of this report. No follow-up attempts are possible; information about lot or batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482503
Sex: M
Age:
State: IL

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: upper respiratory infection; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on 12Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced upper respiratory infection on an unspecified date. The patient received treatment with Z-Pak (azithromycin), an antibiotic and prednisone for 3 days. The outcome of the event was unknown. It was reported that, he was scheduled to receive the second dose of the Pfizer COVID vaccine this Friday (02Apr2021) and wanted to know if he can go ahead and take his second dose of the vaccine. Caller stated on Monday his primary care prescribed a Z-pack and prednisone steroids for an upper respiratory infection. Patient wanted to know if it is okay to receive the second dose of the vaccine this Friday. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm